ZYRTEC®

Children’s ZYRTEC® Allergy Syrup Dosage 

Effective allergy relief in a sugar-free, dye-free syrup formulation in kid-friendly grape and bubble gum flavors

Children’s ZYRTEC® has no juice warning on the label, unlike Allegra® 

Children’s ZYRTEC® Chewables Dosage 

Effective allergy relief in dye-free, great-tasting chewables 

Directions: May be taken with or without water. Chew or crush tablets completely before swallowing. 

Active ingredient: Cetirizine HCl 2.5 mg or 10 mg (in each chewable tablet)

Children’s ZYRTEC® Dissolve Tabs Dosage 

Melt-away tablets for 24-hour relief from kids’ indoor and outdoor allergy symptoms

EFFICACY DATA

Children’s ZYRTEC® makes a significant impact on allergy symptoms1*†

Powerful symptom response seen in pediatric patients with seasonal allergic rhinitis (SAR)¹

Efficacy in ages 2 to 6: Children’s ZYRTEC® 5 mg

66% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks¹

Efficacy in ages 6 to 11: Children’s ZYRTEC® 10 mg 

Studies show 37% and 19% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks¹

^{*Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.}

^{†Randomized, placebo-controlled studies of children aged 6 to 11 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.}

^{‡Significant vs placebo.}

^{§ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.}

^{||ZYRTEC® 10 mg vs placebo ratio at ≥50% reduction is 1.88-fold in Study 1 and 1.42-fold in Study 2.}

CONSISTENCY DATA 

ZYRTEC® provides proven, consistent symptom relief

Children’s symptoms improved consistently over a 2-week period*

Reduction from baseline in total symptom severity complex (TSSC)2†

• 37% and 40% reduction observed after 2 weeks of treatment in the 10-mg group

• 63% and 40% reduction observed after 2 weeks of treatment in the 5-mg group

^{*All studies are multicenter, randomized, placebo-controlled, double-blind in children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).}

^{†Adjusted mean change relative to baseline.}

TOLERABILITY DATA

ZYRTEC® is generally well tolerated by children1

In studies of children ages 6 to 11 years:

• 4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)1

• ≤ 1% of ZYRTEC® patients discontinued due to somnolence¹

^References:  

^{1. Data on file. Johnson & Johnson Consumer Inc., McNeil Consumer Health Division. 2. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.}